EBIT
-
Chr. Hansen delivered organic revenue growth of 7% (excluding carmine price effect in the first quarter of 2012/13.
-
ovozymes has acquired Iogen Bio-Products, the industrial enzyme business of Ottawa-based Iogen Corporation for CA$67.5 million.
-
Finnish plant-based nutrition company Raisio has announced what it says are its best-ever quarterly results. Although sales were broadly flat at €148.
-
Biotechnology company Novozymes has reported that all financial targets were met or exceeded for 2013 following a good fourth quarter.